143 related articles for article (PubMed ID: 15852226)
21. Signaling Pathways of Receptors Involved in Platelet Activation and Shedding of These Receptors in Stored Platelets.
Amelirad A; Shamsasenjan K; Akbarzadehlaleh P; Pashoutan Sarvar D
Adv Pharm Bull; 2019 Feb; 9(1):38-47. PubMed ID: 31011556
[TBL] [Abstract][Full Text] [Related]
22. Interaction between platelets and endothelium: from pathophysiology to new therapeutic options.
Hamilos M; Petousis S; Parthenakis F
Cardiovasc Diagn Ther; 2018 Oct; 8(5):568-580. PubMed ID: 30498682
[TBL] [Abstract][Full Text] [Related]
23. Thrombus Formation and Propagation in the Onset of Cardiovascular Events.
Asada Y; Yamashita A; Sato Y; Hatakeyama K
J Atheroscler Thromb; 2018 Aug; 25(8):653-664. PubMed ID: 29887539
[TBL] [Abstract][Full Text] [Related]
24. Loss of vascular expression of nucleoside triphosphate diphosphohydrolase-1/CD39 in hypertension.
Roy C; Tabiasco J; Caillon A; Delneste Y; Merot J; Favre J; Guihot AL; Martin L; Nascimento DC; Ryffel B; Robson SC; Sévigny J; Henrion D; Kauffenstein G
Purinergic Signal; 2018 Mar; 14(1):73-82. PubMed ID: 29236227
[TBL] [Abstract][Full Text] [Related]
25. Nanoliposomes for Safe and Efficient Therapeutic mRNA Delivery: A Step Toward Nanotheranostics in Inflammatory and Cardiovascular Diseases as well as Cancer.
Abraham MK; Peter K; Michel T; Wendel HP; Krajewski S; Wang X
Nanotheranostics; 2017; 1(2):154-165. PubMed ID: 29071184
[No Abstract] [Full Text] [Related]
26. ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.
Degen H; Borst O; Ziegler M; Mojica Munoz AK; Jamasbi J; Walker B; Göbel S; Fassbender J; Adler K; Brandl R; Münch G; Lorenz R; Siess W; Gawaz M; Ungerer M
J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751543
[TBL] [Abstract][Full Text] [Related]
27. Utility of microfluidic devices to study the platelet-endothelium interface.
Zilberman-Rudenko J; Sylman JL; Garland KS; Puy C; Wong AD; Searson PC; McCarty OJT
Platelets; 2017 Jul; 28(5):449-456. PubMed ID: 28358586
[TBL] [Abstract][Full Text] [Related]
28. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
[TBL] [Abstract][Full Text] [Related]
29. Flow-dependent expression of ectonucleotide tri(di)phosphohydrolase-1 and suppression of atherosclerosis.
Kanthi Y; Hyman MC; Liao H; Baek AE; Visovatti SH; Sutton NR; Goonewardena SN; Neral MK; Jo H; Pinsky DJ
J Clin Invest; 2015 Aug; 125(8):3027-36. PubMed ID: 26121751
[TBL] [Abstract][Full Text] [Related]
30. Mdivi-1 Protects Against Ischemic Brain Injury via Elevating Extracellular Adenosine in a cAMP/CREB-CD39-Dependent Manner.
Cui M; Ding H; Chen F; Zhao Y; Yang Q; Dong Q
Mol Neurobiol; 2016 Jan; 53(1):240-253. PubMed ID: 25428621
[TBL] [Abstract][Full Text] [Related]
31. Extract from Ribes nigrum leaves in vitro activates nitric oxide synthase (eNOS) and increases CD39 expression in human endothelial cells.
Luzak B; Boncler M; Rywaniak J; Dudzinska D; Rozalski M; Krajewska U; Balcerczak E; Podsedek A; Redzynia M; Watala C
J Physiol Biochem; 2014 Dec; 70(4):1007-19. PubMed ID: 25407137
[TBL] [Abstract][Full Text] [Related]
32. Immune modulation in xenotransplantation.
Boksa M; Zeyland J; Słomski R; Lipiński D
Arch Immunol Ther Exp (Warsz); 2015 Jun; 63(3):181-92. PubMed ID: 25354539
[TBL] [Abstract][Full Text] [Related]
33. Syntaxin-binding protein STXBP5 inhibits endothelial exocytosis and promotes platelet secretion.
Zhu Q; Yamakuchi M; Ture S; de la Luz Garcia-Hernandez M; Ko KA; Modjeski KL; LoMonaco MB; Johnson AD; O'Donnell CJ; Takai Y; Morrell CN; Lowenstein CJ
J Clin Invest; 2014 Oct; 124(10):4503-16. PubMed ID: 25244095
[TBL] [Abstract][Full Text] [Related]
34. Optimizing human apyrase to treat arterial thrombosis and limit reperfusion injury without increasing bleeding risk.
Moeckel D; Jeong SS; Sun X; Broekman MJ; Nguyen A; Drosopoulos JH; Marcus AJ; Robson SC; Chen R; Abendschein D
Sci Transl Med; 2014 Aug; 6(248):248ra105. PubMed ID: 25100739
[TBL] [Abstract][Full Text] [Related]
35. Combination treatment of r-tPA and an optimized human apyrase reduces mortality rate and hemorrhagic transformation 6h after ischemic stroke in aged female rats.
Tan Z; Li X; Turner RC; Logsdon AF; Lucke-Wold B; DiPasquale K; Jeong SS; Chen R; Huber JD; Rosen CL
Eur J Pharmacol; 2014 Sep; 738():368-73. PubMed ID: 24933645
[TBL] [Abstract][Full Text] [Related]
36. Low-dose levodopa protects nerve cells from oxidative stress and up-regulates expression of pCREB and CD39.
Zhong SY; Chen YX; Fang M; Zhu XL; Zhao YX; Liu XY
PLoS One; 2014; 9(4):e95387. PubMed ID: 24743653
[TBL] [Abstract][Full Text] [Related]
37. Regulation of ecto-apyrase CD39 (ENTPD1) expression by phosphodiesterase III (PDE3).
Baek AE; Kanthi Y; Sutton NR; Liao H; Pinsky DJ
FASEB J; 2013 Nov; 27(11):4419-28. PubMed ID: 23901069
[TBL] [Abstract][Full Text] [Related]
38. Kindlin-2 regulates hemostasis by controlling endothelial cell-surface expression of ADP/AMP catabolic enzymes via a clathrin-dependent mechanism.
Pluskota E; Ma Y; Bledzka KM; Bialkowska K; Soloviev DA; Szpak D; Podrez EA; Fox PL; Hazen SL; Dowling JJ; Ma YQ; Plow EF
Blood; 2013 Oct; 122(14):2491-9. PubMed ID: 23896409
[TBL] [Abstract][Full Text] [Related]
39. Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?
Hohmann JD; Wang X; Krajewski S; Selan C; Haller CA; Straub A; Chaikof EL; Nandurkar HH; Hagemeyer CE; Peter K
Blood; 2013 Apr; 121(16):3067-75. PubMed ID: 23380744
[TBL] [Abstract][Full Text] [Related]
40. Atherosclerosis: from biology to pharmacological treatment.
Riccioni G; Sblendorio V
J Geriatr Cardiol; 2012 Sep; 9(3):305-17. PubMed ID: 23097661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
